These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 406)

  • 1. Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver.
    Leighton F; Coloma L; Koenig C
    J Cell Biol; 1975 Nov; 67(2PT.1):281-309. PubMed ID: 406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on peroxisomes. V. Effect of ethyl p-chlorophenoxyisobutyrate on the centrifugal behavior of rat liver peroxisomes.
    Hayashi H; Suga T; Ninobe S
    J Biochem; 1975 Jun; 77(6):1199-204. PubMed ID: 5399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
    Flatmark T; Christiansen EN; Kryvi H
    Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proliferative response of hepatic peroxidomes of neonatal rats to treatment with SU-13 437 (nafenopin).
    Stäubli W; Schweizer W; Suter J; Weibel ER
    J Cell Biol; 1977 Sep; 74(3):665-89. PubMed ID: 903369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochemical and immunocytochemical study on the peroxisomes of rat liver after administration of a hypolipidemic drug, MLM-160.
    Yokota S
    Eur J Cell Biol; 1990 Oct; 53(1):112-21. PubMed ID: 1981745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a catalase-negative sub-population of peroxisomes induced in mouse liver by clofibrate.
    Klucis E; Crane DI; Hughes JL; Poulos A; Masters CJ
    Biochim Biophys Acta; 1991 Jul; 1074(2):294-301. PubMed ID: 1676600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat liver peroxisomes. I. New peroxisome population induced by thyroid hormones in the liver of male rats.
    Just WW; Hartl FU; Schimassek H
    Eur J Cell Biol; 1982 Feb; 26(2):249-54. PubMed ID: 6121707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clofibrate application on morphology and enzyme content of liver peroxisomes.
    Goldenberg H; Hüttinger M; Kampfer P; Kramar R; Pavelka M
    Histochemistry; 1976 Feb; 46(3):189-96. PubMed ID: 1248951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual responses of rat hepatic and renal peroxisomes to RMI 14, 514, a new hypolipidemic agent.
    Svoboda DJ
    J Cell Biol; 1978 Sep; 78(3):810-22. PubMed ID: 29903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of rat liver peroxisomes.
    Baudhuin P
    Methods Enzymol; 1974; 31():356-68. PubMed ID: 4153621
    [No Abstract]   [Full Text] [Related]  

  • 11. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response.
    Reddy JK; Azarnoff DL; Svoboda DJ; Prasad JD
    J Cell Biol; 1974 May; 61(2):344-58. PubMed ID: 4208071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of subtotal hepatectomy on peroxisomes and peroxisomal enzymes of rat liver and isolated liver cell fractions.
    Goldenberg H; Hüttinger M; Böck P; Kramar R
    Histochemistry; 1975 Jul; 44(1):47-56. PubMed ID: 52639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.
    Moody DE; Reddy JK
    Am J Pathol; 1978 Feb; 90(2):435-46. PubMed ID: 623209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver peroxisomal fatty acid oxidizing system during aging in control and clofibrate-treated mice.
    Périchon R; Bourre JM
    Biochem Mol Biol Int; 1995 Oct; 37(3):475-80. PubMed ID: 8595387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of clofibrate on amphibian hepatic peroxisomes.
    Ciolek E; Dauça M
    Biol Cell; 1991; 71(3):313-20. PubMed ID: 1681969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
    Reddy J; Svoboda D; Azarnoff D
    Biochem Biophys Res Commun; 1973 May; 52(2):537-43. PubMed ID: 4711169
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in peroxisomes and mitochondria in liver of ethionine exposed rats: a biochemical and morphological investigation.
    Aarsaether N; Aarsland A; Kryvi H; Nilsson A; Svardal A; Ueland PM; Berge RK
    Carcinogenesis; 1989 Jun; 10(6):987-94. PubMed ID: 2498002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An electron microscopic and enzymic study of rat liver peroxisomal nucleoid core and its association with urate oxidase.
    Lata GF; Mamrak F; Bloch P; Baker B
    J Supramol Struct; 1977; 7(3-4):419-34. PubMed ID: 616489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of inflammation on peroxisomal enzyme activities, catalase synthesis, and lipid metabolism.
    Canonico PG; Rill W; Ayala E
    Lab Invest; 1977 Nov; 37(5):479-86. PubMed ID: 21326
    [No Abstract]   [Full Text] [Related]  

  • 20. The synthesis and turnover of rat liver peroxisomes. I. Fractionation of peroxisome proteins.
    Leighton F; Poole B; Lazarow PB; De Duve C
    J Cell Biol; 1969 May; 41(2):521-35. PubMed ID: 4389026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.